Company profile
HYPERFINE, INC.
NASDAQ:HYPRBiotechnology: Electromedical & Electrotherapeutic Apparatus
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07296263 | — | active_not_recruiting | 2025-12-30 | 2026-10-31 | Hyperfine | Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems |
FDA applications (0)
No records yet.